Anticancer Research Study's Role in Talcum Powder Lawsuit News
The medical journal Anticancer Research continues to pop up in talcum powder ovarian cancer lawsuit news for its mention of a 33 percent increased risk for ovarian cancer for women who regularly used talcum powder.
Monday, February 1, 2016 - One of the most valuable resources for plaintiffs in recent talcum powder lawsuit news has been a 2003 research study that noted a high correlation between the talcum powder and an increased risk in ovarian cancer. The medical journal Anticancer Research found that women they researched were 33 percent more susceptible to ovarian cancer when they were found to have used talcum powder regularly in the past.
Hundreds of talcum powder plaintiffs around the country are now using the study to bolster their lawsuits claiming that given the amount of research that supported a significant link between talcum powder and ovarian cancer, Johnson & Johnson (J&J) was likely to have been aware of this connection and chose to keep the information from consumers.
The high figure that Anticancer Research came up with to represent the percentage that a woman's risk increased for ovarian cancer after the regular use of talcum was determined with one of the largest data sets in talcum powder research. More than 12,000 subjects were examined over 16 research studies that the Anticancer Research article looked into when making its determinations regarding the potential carcinogenic properties of talcum powder. The Anticancer Research study took that data from each of the 16 former studies and pooled their averaged to arrive at the conclusion that the regular use of talcum powder increased the risk of ovarian cancer by 33 percent.
The study however was not able to state that this outcome was a wholly definitive result, as the methods used to carry out the study were susceptible to a selection bias. This did not render the value of the 33 percent finding insignificant. The figure may not have been able to represent a "clear dose-response relationship," but its existence gave the researchers a clear indication that some part of the relationship between talcum powder and an increased risk in the contraction of ovarian cancer was significant. The study also allowed future research to take the combined data from the 16 studies examined in the Anticancer Research article and have a further developed jumping off point for their talcum powder investigations.
The high percentage representing the increased risk of ovarian cancer as a result of the regular use of talcum powder has made the study awfully popular among plaintiffs filing suit against J&J and has caused it to show up regularly in talcum powder ovarian cancer lawsuit news. More than 1,000 lawsuits against J&J are currently pending throughout the country, with most of them using multiple research studies to supplement their arguments against the defendants.
Talcum powder studies have been receiving publication since the early 1970's, with more than 20 being conducted since the first was released in 1971 by the British Journal of Obstetrics and Gynaecology. While J&J has relied on a number of them which have failed to find a significant link between talcum powder and ovarian cancer, plaintiffs feel confident that the amount of research supporting their arguments are sufficient to successfully win damages from the defendant for their negligent marketing and disregard for consumer welfare. The plaintiffs will be looking at talcum powder cancer lawsuit news as litigation progresses throughout the country for any future updates to the current landscape of talcum powder research that could bolster their evidentiary findings against J&J.
OnderLaw, LLC -